OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Viability fingerprint of glioblastoma cell lines: roles of mitotic, proliferative, and epigenetic targets
Darja Lavõgina, Tõnis Laasfeld, Markus Vardja, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 5
Darja Lavõgina, Tõnis Laasfeld, Markus Vardja, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 5
Showing 5 citing articles:
Revisiting the Resazurin-Based Sensing of Cellular Viability: Widening the Application Horizon
Darja Lavõgina, Helen Lust, Maris‐Johanna Tahk, et al.
Biosensors (2022) Vol. 12, Iss. 4, pp. 196-196
Open Access | Times Cited: 62
Darja Lavõgina, Helen Lust, Maris‐Johanna Tahk, et al.
Biosensors (2022) Vol. 12, Iss. 4, pp. 196-196
Open Access | Times Cited: 62
Inhibition of epigenetic and cell cycle-related targets in glioblastoma cell lines reveals that onametostat reduces proliferation and viability in both normoxic and hypoxic conditions
Darja Lavõgina, Mattias Kaspar Krõlov, Hans Vellama, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Darja Lavõgina, Mattias Kaspar Krõlov, Hans Vellama, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Immune checkpoint inhibitors modulate the cytotoxic effect of chemotherapy in lung adenocarcinoma cells
M. Saar, Darja Lavõgina, Helen Lust, et al.
Oncology Letters (2023) Vol. 25, Iss. 4
Open Access | Times Cited: 7
M. Saar, Darja Lavõgina, Helen Lust, et al.
Oncology Letters (2023) Vol. 25, Iss. 4
Open Access | Times Cited: 7
Exploring the Molecular Players behind the Potentiation of Chemotherapy Effects by Durvalumab in Lung Adenocarcinoma Cell Lines
M. Saar, Jana Jaal, Alvin Meltsov, et al.
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1485-1485
Open Access | Times Cited: 1
M. Saar, Jana Jaal, Alvin Meltsov, et al.
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1485-1485
Open Access | Times Cited: 1
Inhibition of epigenetic and cell cycle-related targets in glioblastoma cell lines: onametostat reduces proliferation and viability in both normoxic and hypoxic conditions
Darja Lavõgina, Mattias Kaspar Krõlov, Hans Vellama, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Darja Lavõgina, Mattias Kaspar Krõlov, Hans Vellama, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
